Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.
This article is protected by copyright. All rights reserved.
PMID: 32779201 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla C Tags: J Clin Pharmacol Source Type: research
More News: Clinical Trials | COVID-19 | Drugs & Pharmacology | Pandemics | Respiratory Medicine | SARS